ALZpath, Inc., 2026-07-21
An SEC Form D private-offering notice from Carlsbad, CA, a $10,411,219 filer-stated offering target in Biotech. Filed 2026-07-21. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Developer of a blood based diagnostic test using a proprietary pTau217 antibody to aid early detection of Alzheimer's disease.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Flipur Technologies, Inc, 2026-07-21, $2M, Huntington Beach, CA
- Cue Biopharma, Inc., 2026-07-22, $50M, Boston, MA
- Intermezzo Inc. / DE /, 2026-07-21, $10.3M, Menlo Park, CA
- Oncotelic Therapeutics, Inc., 2026-07-22, $712K, Agoura Hills, CA
- Mentium Technologies Inc., 2026-07-21, $8.8M, Goleta, CA
- Holobiome, Inc., 2026-07-22, $10M, Boston, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.